New York personal injury lawyers like me welcome this news: The Food and Drug Administration recently approved a new kind of blood test that can detect concussions and identify possible brain injuries. It’s called the “Banyan Brain Trauma Indicator” (“BBTI”). The test works by measuring the levels of proteins, known as UCH-L1, and GFAP, that a damaged brain releases into the blood. Higher levels of these blood proteins indicate intracranial lesions.
There are several advantages of BBTI over traditional CT scans (which is how brain lesions at present are usually detected). First, the blood test does not expose the brain to radiation as a CT scan does. Second, the blood test will make for a speedier diagnosis of a brain injury. But my hope is that the test will one day also be used to detect small lesions that today’s CT scans cannot detect.
Why is this last thing important?